A detailed history of Smith, Salley & Associates transactions in Medtronic PLC stock. As of the latest transaction made, Smith, Salley & Associates holds 173,168 shares of MDT stock, worth $15.5 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares
173,168
Previous 156,766 10.46%
Holding current value
$15.5 Million
Previous $12.3 Million 26.35%
% of portfolio
1.05%
Previous 0.91%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$76.84 - $91.03 $1.26 Million - $1.49 Million
16,402 Added 10.46%
173,168 $15.6 Million
Q2 2024

Jul 29, 2024

BUY
$78.71 - $87.02 $242,426 - $268,021
3,080 Added 2.0%
156,766 $12.3 Million
Q1 2024

May 02, 2024

SELL
$82.84 - $88.09 $2.97 Million - $3.15 Million
-35,801 Reduced 18.89%
153,686 $13.4 Million
Q4 2023

Jan 24, 2024

BUY
$69.43 - $83.43 $153,509 - $184,463
2,211 Added 1.18%
189,487 $15.6 Million
Q3 2023

Oct 27, 2023

BUY
$78.22 - $90.4 $507,334 - $586,334
6,486 Added 3.59%
187,276 $14.7 Million
Q2 2023

Aug 04, 2023

BUY
$79.47 - $91.38 $179,920 - $206,884
2,264 Added 1.27%
180,790 $15.9 Million
Q1 2023

May 03, 2023

BUY
$76.72 - $87.58 $3.28 Million - $3.75 Million
42,783 Added 31.52%
178,526 $14.4 Million
Q4 2022

Feb 03, 2023

SELL
$76.18 - $87.74 $4.07 Million - $4.68 Million
-53,385 Reduced 28.23%
135,743 $10.6 Million
Q3 2022

Nov 01, 2022

BUY
$80.75 - $95.31 $104,975 - $123,903
1,300 Added 0.69%
189,128 $15.3 Million
Q2 2022

Aug 01, 2022

BUY
$87.4 - $113.09 $728,391 - $942,492
8,334 Added 4.64%
187,828 $16.9 Million
Q1 2022

May 10, 2022

BUY
$100.58 - $112.38 $1.02 Million - $1.14 Million
10,139 Added 5.99%
179,494 $19.9 Million
Q4 2021

Feb 10, 2022

SELL
$99.53 - $127.75 $11,147 - $14,308
-112 Reduced 0.07%
169,355 $17.5 Million
Q3 2021

Nov 05, 2021

BUY
$122.75 - $135.17 $362,971 - $399,697
2,957 Added 1.78%
169,467 $21.2 Million
Q2 2021

Aug 09, 2021

BUY
$118.19 - $131.5 $524,763 - $583,860
4,440 Added 2.74%
166,510 $20.7 Million
Q1 2021

Apr 30, 2021

BUY
$111.18 - $119.74 $717,666 - $772,921
6,455 Added 4.15%
162,070 $19.1 Million
Q4 2020

Jan 28, 2021

BUY
$100.57 - $117.14 $691,821 - $805,806
6,879 Added 4.62%
155,615 $18.2 Million
Q3 2020

Nov 05, 2020

BUY
$90.13 - $108.78 $2.23 Million - $2.7 Million
24,777 Added 19.99%
148,736 $15.5 Million
Q2 2020

Aug 04, 2020

BUY
$84.11 - $103.33 $1.81 Million - $2.23 Million
21,553 Added 21.05%
123,959 $11.4 Million
Q1 2020

Apr 24, 2020

SELL
$72.92 - $121.3 $1.23 Million - $2.05 Million
-16,916 Reduced 14.18%
102,406 $9.24 Million
Q4 2019

Jan 27, 2020

SELL
$104.49 - $114.54 $42,527 - $46,617
-407 Reduced 0.34%
119,322 $13.5 Million
Q3 2019

Oct 30, 2019

BUY
$98.02 - $111.18 $503,528 - $571,131
5,137 Added 4.48%
119,729 $13 Million
Q2 2019

Jul 12, 2019

BUY
$84.15 - $99.38 $301,341 - $355,879
3,581 Added 3.23%
114,592 $11.2 Million
Q1 2019

May 03, 2019

BUY
$82.45 - $93.79 $2.23 Million - $2.53 Million
27,023 Added 32.17%
111,011 $10.1 Million
Q4 2018

Feb 05, 2019

BUY
$85.8 - $99.49 $6.75 Million - $7.82 Million
78,616 Added 1463.44%
83,988 $7.64 Million
Q3 2018

Nov 06, 2018

BUY
$85.91 - $99.17 $9,364 - $10,809
109 Added 2.07%
5,372 $528,000
Q2 2018

Aug 10, 2018

BUY
$77.48 - $87.83 $3,099 - $3,513
40 Added 0.77%
5,263 $451,000
Q1 2018

May 09, 2018

SELL
$76.55 - $87.26 $21,280 - $24,258
-278 Reduced 5.05%
5,223 $419,000
Q4 2017

Feb 12, 2018

SELL
$76.93 - $83.5 $9,231 - $10,020
-120 Reduced 2.13%
5,501 $444,000
Q3 2017

Nov 02, 2017

BUY
$77.71 - $84.6 $436,807 - $475,536
5,621
5,621 $437,000

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $119B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Smith, Salley & Associates Portfolio

Follow Smith, Salley & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Salley & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Smith, Salley & Associates with notifications on news.